| Patent application number | Description | Published |
|---|
| 20080226634 | TES7 AND ANTIBODIES THAT BIND THERETO - The invention provides the identification and characterization of disease and cancer-associated antigen, TES7. The invention also provides a family of monoclonal antibodies that bind to antigen TES7, methods of diagnosing and treating various human cancers and diseases that express TES7. | 09-18-2008 |
| 20090202561 | NOVEL RAAG10 CELL SURFACE TARGET AND A FAMILY OF ANTIBODIES RECOGNIZING THAT TARGET - The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10. | 08-13-2009 |
| 20090263391 | ANTIBODIES THAT BIND TO EPHA2 AND METHODS OF USE THEREOF - Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed. | 10-22-2009 |
| 20090269340 | ANTIBODIES TO ONCOSTATIN M RECEPTOR - The invention provides characterization of the disease and cancer-associated antigen, OSM-R.beta. The invention also provides modulators of OSM-R.beta, including a family of monoclonal antibodies that bind to antigen OSM-R.beta, and methods of diagnosing and treating various human cancers and diseases associated with OSM-R.beta. | 10-29-2009 |
| 20100086969 | Antibodies That Bind to EphA2 and Methods of Use Thereof - Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed. | 04-08-2010 |
| 20100111951 | ADAM-9 Modulators - The invention provides the identification and characterization of a disease and cancer-associated antigen, KID24. The invention also provides modulators of KID24, including a family of monoclonal antibodies that bind to antigen KID24, and methods of diagnosing and treating various human cancers and diseases with KID24. | 05-06-2010 |
| 20100150921 | KID31 And Antibodies That Bind Thereto - The invention provides the identification and characterization of a disease and cancer-associated antigen, KID31. The invention also provides modulators of KID31, including a family of monoclonal antibodies that bind to antigen KID31, and methods of diagnosing and treating various human cancers and diseases with KID31. | 06-17-2010 |
| 20100166745 | TRANSFERRIN RECEPTOR ANTIBODIES - The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor. | 07-01-2010 |
| 20100183605 | TES7 AND ANTIBODIES THAT BIND THERETO - The invention provides the identification and characterization of a disease and cancer-associated antigen, TES7. The invention also provides a family of monoclonal antibodies that bind to antigen TES7, methods of diagnosing and treating various human cancers and diseases with TES7. | 07-22-2010 |
| 20110045006 | LUCA2 and Antibodies That Bind Thereto - The invention provides the identification and characterization of disease and cancer-associated antigen, LUCA2. The invention also provides a family of monoclonal antibodies that bind to antigen LUCA2, methods of diagnosing and treating various human cancers and diseases that express LUCA2. | 02-24-2011 |
